CJ CheilJedang teams with ADM to form US animal feed amino acids joint venture

• CJ Corp unit CJ CheilJedang signed a contribution agreement with ADM to form a global animal feed amino acids joint venture.
• JV to be owned 63% by CJ Bio America, 37% by ADM, using in-kind contributions of related operating assets.
• Partnership targets stronger competitiveness in feed amino acids, tighter global collaboration, more stable raw-material sourcing.
• CJ Corp backstops certain JV losses if CJ Bio America fails to indemnify ADM within 30 days of written notice.
• Agreement date set at Oct. 2, 2026, subject to regulatory clearances, including merger filing approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CJ Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002800987), on October 02, 2026, and is solely responsible for the information contained therein.